References
- MurrayCJBarberRMForemanKJGlobal, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transitionLancet2015386100092145219126321261
- MiravitllesMWorthHSoler CatalunaJJObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS studyRespir Res20141512225331383
- PartridgeMRKarlssonNSmallIRPatient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet surveyCurr Med Res Opin20092582043204819569976
- van BuulARKasteleynMJChavannesNHTaubeCAssociation between morning symptoms and physical activity in COPD: a systematic reviewEur Respir Rev20172614316003328049127
- van BuulARKasteleynMJChavannesNHTaubeCMorning symptoms in COPD: a treatable yet often overlooked factorExpert Rev Respir Med201711431132228282500
- KimYJLeeBKJungCYPatient’s perception of symptoms related to morning activity in chronic obstructive pulmonary disease: the SYMBOL StudyKorean J Intern Med201227442643523269884
- TsiligianniIMettingEvan der MolenTChavannesNMorning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRGNPJ Prim Care Respir Med2016261604027442618
- PittaFTroostersTSpruitMAProbstVSDecramerMGosselinkRCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171997297715665324
- TroostersTSciurbaFBattagliaSPhysical inactivity in patients with COPD: a controlled multi-center pilot-studyRespir Med201010471005101120167463
- Donaire-GonzalezDGimeno-SantosEBalcellsEPhysical activity in COPD patients: patterns and boutsEur Respir J2013424993100223258786
- BrawnerCAChurillaJRKeteyianSJPrevalence of physical activity is lower among individuals with chronic diseaseMed Sci Sports Exerc20164861062106726741117
- Garcia-AymerichJLangePBenetMSchnohrPAntoJMRegular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort studyThorax200661977277816738033
- EstebanCQuintanaJMAburtoMImpact of changes in physical activity on health-related quality of life among patients with COPDEur Respir J201036229230020075059
- O’HaganPChavannesNHThe impact of morning symptoms on daily activities in chronic obstructive pulmonary diseaseCurr Med Res Opin201430230131424195740
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and prevention of COPD; 2017 [updated 2017] Available from: http://www.goldcopd.org/Accessed: May 16, 2017
- AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
- MarinJMBeehKMClemensAEarly bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)Int J Chron Obstruct Pulmon Dis2016111425143427418815
- HaskellWLLeeIMPateRRPhysical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart AssociationMed Sci Sports Exerc20073981423143417762377
- RabinovichRALouvarisZRasteYValidity of physical activity monitors during daily life in patients with COPDEur Respir J20134251205121523397303
- Van RemoortelHGiavedoniSRasteYValidity of activity monitors in health and chronic disease: a systematic reviewInt J Behav Nutr Phys Act201298422776399
- Van RemoortelHRasteYLouvarisZValidity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetryPloS one201276e3919822745715
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
- CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- QuanjerPHStanojevicSColeTJMulti-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equationsEur Respir J20124061324134322743675
- CrieeCPSorichterSSmithHJBody plethysmography – its principles and clinical useRespir Med2011105795997121356587
- CasanovaCMarinJMMartinez-GonzalezCNew GOLD classification: longitudinal data on group assignmentRespir Res201415324417879
- JonesPWNadeauGSmallMAdamekLCharacteristics of a COPD population categorised using the GOLD framework by health status and exacerbationsRespir Med2014108112913524041746
- RocheNSmallMBroomfieldSHigginsVPollardRReal world COPD: association of morning symptoms with clinical and patient reported outcomesCOPD201310667968624127914
- MiravitllesMWorthHSoler-CatalunaJJThe relationship between 24-hour symptoms and copd exacerbations and healthcare resource use: results from an observational study (ASSESS)COPD201613556156826983349
- TsiligianniIMettingEvan der MolenTChavannesNKocksJMorning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRGNPJ Prim Care Respir Med2016261604027442618
- LangePMarottJLVestboJNordestgaardBGPrevalence of nighttime dyspnoea in COPD and its implications for prognosisEur Respir J20144361590159824488571
- BatemanEDChapmanKRSinghDAclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)Respir Res2015169226233481
- RennardSDecramerMCalverleyPMImpact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International SurveyEur Respir J200220479980512412667
- KesslerRPartridgeMRMiravitllesMSymptom variability in patients with severe COPD: a pan-European cross-sectional studyEur Respir J201137226427221115606
- StephensonJJCaiQMocarskiMTanHDoshiJASullivanSDImpact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20151057758625844033
- ThyregodMBodtgerUCoherence between self-reported and objectively measured physical activity in patients with chronic obstructive lung disease: a systematic reviewInt J Chron Obstruct Pulmon Dis2016112931293827932873
- Van HeesVTSlootmakerSMDe GrootGVan MechelenWVan LummelRCReproducibility of a triaxial seismic accelerometer (DynaPort)Med Sci Sports Exerc200941481081719276852
- Soler-CatalunaJJSauledaJValdesLPrevalence and perception of 24-hour symptom patterns in patients with stable chronic obstructive pulmonary disease in SpainArch Bronconeumol201652630831526774700
- WaschkiBKirstenAMHolzODisease progression and changes in physical activity in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015192329530626020495
- WatzHWaschkiBBoehmeCClaussenMMeyerTMagnussenHExtrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional studyAm J Respir Crit Care Med2008177774375118048807